Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman F Staats

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Infection and Immunity|August 22, 2007
In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunityHerman F Staats, S Munir Alam, Richard M Scearce, et al.
Vaccine|January 29, 2013
A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigenWilliam M Gwinn, Brandi T Johnson, Shaun M Kirwan, et al.
Nature Immunology|November 5, 2003
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infectionJames B McLachlan, Justin P Hart, Salvatore V Pizzo, et al.
NPJ Vaccines|February 13, 2020
Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacyAshley L St John, Hae Woong Choi, Q David Walker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph nodeJoseph M Thompson, Michael G Nicholson, Alan C Whitmore, et al.
International Journal of Pharmaceutics|February 2, 2023
Delivery of small molecule mast cell activators for West Nile Virus vaccination using acetalated dextran microparticlesDylan A Hendy, Brandi T Johnson-Weaver, Cole J Batty, et al.
Vaccine|July 7, 2015
Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellersLouise Roggelin, Christof D Vinnemeier, Johanna Fischer-Herr, et al.
Nature Medicine|April 22, 2008
Mast cell activators: a new class of highly effective vaccine adjuvantsJames B McLachlan, Christopher P Shelburne, Justin P Hart, et al.
Plos One|February 10, 2011
Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbitsHerman F Staats, Jeffrey R Fielhauer, Afton L Thompson, et al.
Medchemcomm|May 14, 2013
A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating AgentsHerman F Staats, Shaun M Kirwan, Hae Woong Choi, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Infection and Immunity|August 22, 2007
In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunityHerman F Staats, S Munir Alam, Richard M Scearce, et al.
Vaccine|January 29, 2013
A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigenWilliam M Gwinn, Brandi T Johnson, Shaun M Kirwan, et al.
Nature Immunology|November 5, 2003
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infectionJames B McLachlan, Justin P Hart, Salvatore V Pizzo, et al.
NPJ Vaccines|February 13, 2020
Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacyAshley L St John, Hae Woong Choi, Q David Walker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph nodeJoseph M Thompson, Michael G Nicholson, Alan C Whitmore, et al.
International Journal of Pharmaceutics|February 2, 2023
Delivery of small molecule mast cell activators for West Nile Virus vaccination using acetalated dextran microparticlesDylan A Hendy, Brandi T Johnson-Weaver, Cole J Batty, et al.
Vaccine|July 7, 2015
Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellersLouise Roggelin, Christof D Vinnemeier, Johanna Fischer-Herr, et al.
Nature Medicine|April 22, 2008
Mast cell activators: a new class of highly effective vaccine adjuvantsJames B McLachlan, Christopher P Shelburne, Justin P Hart, et al.
Plos One|February 10, 2011
Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbitsHerman F Staats, Jeffrey R Fielhauer, Afton L Thompson, et al.
Medchemcomm|May 14, 2013
A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating AgentsHerman F Staats, Shaun M Kirwan, Hae Woong Choi, et al.
Pageof 8